Protagonist Therapeutics Inc (PTGX)
Operating Income Growth
477.65%
Quarterly · Period ending:
PTGX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported477.65%period ending
Latest reported477.65%period ending
PTGX Quarterly Operating Income YoY % (-161.81% → 477.65%)
Year-over-year change
High-resolution chart · PNG
PTGX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 477.6456% | |
| 81.1082% | |
| -139.7184% | |
| -11.9847% | |
| -8.3726% | |
| -109.3597% | |
| 450.0456% | |
| -8.159% | |
| 8.4077% | |
| 672.7465% | |
| 163.1203% | |
| -18.6453% | |
| -2.1982% | |
| -70.6267% | |
| 3.6924% | |
| 4.7839% | |
| -34.1979% | |
| 12.1144% | |
| -101.3595% | |
| -336.5157% | |
| -69.523% | |
| -21.9526% | |
| -8.8502% | |
| 54.7271% | |
| 41.997% | |
| -34.4689% | |
| -12.2437% | |
| -82.8416% | |
| -239.9394% | |
| -78.0046% | |
| -338.7134% | |
| -88.5341% | |
| 38.9399% | |
| 42.3457% | |
| 69.1761% | |
| 30.2326% | |
| -113.3832% | |
| -102.7415% | |
| -127.8944% | |
| -77.518% | |
| -130.0032% | |
| -161.8074% |